- Home
- PRPO vs MEGL Comparison
PRPO vs MEGL Comparison
Compare PRPO & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- MEGL
- Stock Information
- Founded
- PRPO N/A
- MEGL 2016
- Country
- PRPO United States
- MEGL Hong Kong
- Employees
- PRPO N/A
- MEGL N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- MEGL Finance: Consumer Services
- Sector
- PRPO Industrials
- MEGL Finance
- Exchange
- PRPO Nasdaq
- MEGL Nasdaq
- Market Cap
- PRPO 17.1M
- MEGL 6.3M
- IPO Year
- PRPO N/A
- MEGL 2022
- Fundamental
- Price
- PRPO $14.51
- MEGL $1.51
- Analyst Decision
- PRPO
- MEGL
- Analyst Count
- PRPO 0
- MEGL 0
- Target Price
- PRPO N/A
- MEGL N/A
- AVG Volume (30 Days)
- PRPO 20.0K
- MEGL 38.7K
- Earning Date
- PRPO 08-12-2025
- MEGL 07-29-2025
- Dividend Yield
- PRPO N/A
- MEGL N/A
- EPS Growth
- PRPO N/A
- MEGL N/A
- EPS
- PRPO N/A
- MEGL N/A
- Revenue
- PRPO $20,029,000.00
- MEGL $1,645,862.00
- Revenue This Year
- PRPO N/A
- MEGL N/A
- Revenue Next Year
- PRPO N/A
- MEGL N/A
- P/E Ratio
- PRPO N/A
- MEGL N/A
- Revenue Growth
- PRPO 26.67
- MEGL N/A
- 52 Week Low
- PRPO $3.90
- MEGL $1.02
- 52 Week High
- PRPO $16.89
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- PRPO 63.53
- MEGL 46.77
- Support Level
- PRPO $13.83
- MEGL $1.42
- Resistance Level
- PRPO $15.47
- MEGL $1.60
- Average True Range (ATR)
- PRPO 1.18
- MEGL 0.07
- MACD
- PRPO -0.01
- MEGL -0.02
- Stochastic Oscillator
- PRPO 62.16
- MEGL 40.09
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.